Apogee Therapeutics, Inc.
APGE
27 insider filings · Latest: Jun 22, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 7 1:00 AM | Carl DambkowskiChief Medical Officer | Sale | 5,500 | $71.06 | $390.8K | 209,773(D) | View → |
| Mar 2, 2026 | Mar 5 1:00 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $70.22 | $140.4K | 181,371(D) | View → |
| Feb 11, 2026 | Feb 14 1:00 AM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 20,000 | $63.35 | $1.3M | 1,172,987(D) | View → |
| Feb 11, 2026 | Feb 11 3:42 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 60,000 | $64.00 | $3.8M | — | View → |
| Feb 4, 2026 | Feb 5 1:02 AM | Carl DambkowskiChief Medical Officer | Sale | 5,500 | $65.79 | $361.9K | 211,148(D) | View → |
| Feb 2, 2026 | Feb 5 1:01 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $65.81 | $131.6K | 183,371(D) | View → |
| Jan 22, 2026 | Jan 23 1:07 AM | Fairmount Funds Management LLCDirector | Sale | 1,750,000 | $76.30 | $133.5M | 298,647(I) | View → |
| Jan 22, 2026 | Jan 23 1:03 AM | Fairmount Healthcare Fund II L.P. | Proposed Sale | 1,750,000 | $76.30 | $133.5M | — | View → |
| Jan 14, 2026 | Jan 17 1:00 AM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 20,000 | $81.11 | $1.6M | 1,192,987(D) | View → |
| Jan 7, 2026 | Jan 7 9:27 PM | CARL DAMBKOWSKI | Proposed Sale | 35,200 | $78.25 | $2.8M | — | View → |
| Jan 2, 2026 | Jan 2 9:31 PM | JANE HENDERSON | Proposed Sale | 12,000 | $75.48 | $905.8K | — | View → |
| Dec 19, 2025 | Dec 19 9:24 PM | JANE HENDERSON | Proposed Sale | 1,500 | $77.35 | $116.0K | — | View → |
| Dec 4, 2025 | Dec 4 9:43 PM | JANE HENDERSON | Proposed Sale | 1,500 | $74.55 | $111.8K | — | View → |
| Dec 4, 2025 | Dec 4 9:41 PM | CARL DAMBKOWSKI | Proposed Sale | 10,900 | $74.55 | $812.6K | — | View → |
| Nov 25, 2025 | Nov 25 9:28 PM | JANE HENDERSON | Proposed Sale | 1,500 | $67.85 | $101.8K | — | View → |
| Nov 14, 2025 | Nov 14 9:31 PM | JANE HENDERSON | Proposed Sale | 2,000 | $62.97 | $125.9K | — | View → |
| Nov 13, 2025 | Nov 13 3:33 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 100,000 | $66.98 | $6.7M | — | View → |
| Nov 11, 2025 | Nov 12 12:03 PM | JANE HENDERSON | Proposed Sale | 1,000 | $56.77 | $56.8K | — | View → |
| Nov 5, 2025 | Nov 5 9:17 PM | CARL DAMBKOWSKI | Proposed Sale | 10,785 | $53.90 | $581.3K | — | View → |
| Jul 2, 2025 | Jul 2 8:22 PM | CARL DAMBKOWSKI | Proposed Sale | 22,345 | $44.26 | $989.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jun 12 12:04 AM | Fairmount Funds Management LLCDirector | Grant/Award | 7,657 | $85.00 | 7,657(I) | View → |
| Jun 9, 2026 | Jun 12 12:03 AM | Nimish P ShahDirector | Grant/Award | 7,657 | $85.00 | 7,657(D) | View → |
| Jun 9, 2026 | Jun 12 12:03 AM | Mark C. MckennaDirector | Grant/Award | 7,657 | $85.00 | 7,657(D) | View → |
| Jun 9, 2026 | Jun 12 12:02 AM | William A Jones JRDirector | Grant/Award | 7,657 | $85.00 | 7,657(D) | View → |
| Jun 9, 2026 | Jun 12 12:01 AM | Jennifer A. FoxDirector | Grant/Award | 7,657 | $85.00 | 7,657(D) | View → |
| Jun 9, 2026 | Jun 12 12:00 AM | Lisa BollingerDirector | Grant/Award | 7,657 | $85.00 | 7,657(D) | View → |
| Jun 3, 2026 | Jun 6 12:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 118,915(D) | View → |
| May 6, 2026 | May 9 12:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 123,040(D) | View → |
| Apr 16, 2026 | Apr 20 8:05 PM | Michael Thomas HendersonDirector, Chief Executive Officer | Option Exercise | 3,000 | $22.86 | 387,012(D) | View → |
| Apr 1, 2026 | Apr 4 12:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 127,165(D) | View → |
| Mar 4, 2026 | Mar 7 1:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 131,290(D) | View → |
| Feb 4, 2026 | Feb 5 1:02 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 135,415(D) | View → |